Revenue is a key feature predominant in many industries. Equally important is balancing revenue desire with revenue life cycles. Biotech for instance is built for massive milestone payments that typically occurs “once”. The payment occurse after validation of science. Revenue is important but understanding its requirements to generate a revenue lifecycle is more important. A factor I preach often in my articles Chris Knight.